The potential of more affordable diabetic care comes in the wake of Swiss major Novartis-owned Vildagliptin losing patent on Monday — a development closely watched for months. Dozens of companies have readied plans to get a slice of the action in the growing Rs 14,000-crore diabetes therapy market, with the number of players expected to cross 50 soon.
from Times of India https://ift.tt/2LEI6Bu
Post Top Ad
Tuesday, December 10, 2019
Price of diabetes drug to halve soon
Tags
# IFTTT
# Times of India
About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.
Times of India
Labels:
IFTTT,
Times of India
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment